Embecta Corp. (EMBC) Stock Forecast

NASDAQ: EMBCAnalyst ratings, price target and estimates.

EMBC analyst forecast

as of October 17, 2026
Analyst consensus
Hold
2.75 / 5 from 4 analysts
Price target
$4.00
average of analyst targets
Upside to target
−36.2%
from the latest close
Next earnings
November 24, 2026
EPS estimate $0.31
52-week range
$2.90 – $14.64

EMBC analyst ratings

4 analysts
Strong buy
00%
Buy
00%
Hold
375%
Sell
125%
Strong sell
00%

Number of analysts at each rating.

EMBC price target

Price $6.27Target $4.00
52-week low $2.9052-week high $14.64

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

EMBC earnings per share estimates

Embecta Corp. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Next quarter (Dec '26)$0.49$0.39$0.67$0.71−30.5%3
Current fiscal year (FY2026)$1.83$1.82$1.85$2.95−37.8%4
Next fiscal year (FY2027)$1.76$1.75$1.77$1.83−4.0%4

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

EMBC revenue estimates

Embecta Corp. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Next quarter (Dec '26)$268.0M$264.9M$274.2M+2.6%3
Current fiscal year (FY2026)$1.02B$1.02B$1.03B−5.1%4
Next fiscal year (FY2027)$1.08B$1.08B$1.08B+5.6%4

EMBC EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

EMBC revenue: reported and forecast

Reported revenueEstimate (average; low–high)

EMBC EPS estimate revisions

Embecta Corp. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Next quarter (Dec '26)$0.49$0.48$0.48$0.48$0.49+0.7%1 up · 0 down
Current fiscal year (FY2026)$1.60$1.83$1.83$1.83$1.83+14.9%3 up · 0 down
Next fiscal year (FY2027)$1.74$1.76$1.76$1.76$1.76+1.3%3 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

EMBC earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; EMBC beat in 11 of 12.

What analysts expect from EMBC

4 analysts cover Embecta; their consensus rating is hold (2.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.00, 36.2% below the latest close of $6.27. Analysts expect earnings of $1.83 per share for FY2026, −37.8% from a year earlier. For FY2027 the average estimate is $1.76 per share on revenue of $1.1 billion. Embecta beat the EPS estimate in 11 of the last 12 quarters.

Related: EMBC income statement, EMBC key metrics, EMBC chart. See the EMBC stock overview for the latest quote and news.

EMBC forecast FAQ

What is Embecta's price target?

The average analyst price target for Embecta is $4.00, 36.2% below the latest close of $6.27.

Is Embecta a buy, hold or sell?

Of 4 analysts covering Embecta, 0 rate it a strong buy, 0 a buy, 3 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

What is Embecta's EPS forecast?

Analysts forecast $1.83 per share for FY2026 (range $1.82 to $1.85); for FY2027 the estimate is $1.76.

What is Embecta's revenue forecast?

The average revenue estimate for FY2026 is $1.0 billion, growth of −5.1%; for FY2027 it is $1.1 billion.

When does Embecta report earnings?

Embecta is expected to report results for the quarter ending September 30, 2026 on November 24, 2026; the EPS estimate is $0.31.

Does Embecta usually beat earnings estimates?

Embecta reported EPS at or above the analyst estimate in 11 of the last 12 quarters.

Medical Instruments & Supplies: forecast